Seeing Is Believing
CYTH is currently covered by 1 analysts with an average price target of $3.86. This is a potential upside of $2.6 (206.35%) from yesterday's end of day stock price of $1.26.
Cyclo Therapeutics's activity chart (see below) currently has 1 price targets and 3 ratings on display. The stock rating distribution of CYTH is 50% HOLD and 50% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 49 days.
Highest price target for CYTH is $4, Lowest price target is $4, average price target is $3.86.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 27-Sep-2023. First documented stock forecast 17-Dec-2020.
Currently out of the existing stock ratings of CYTH, 1 are a HOLD (50%), 1 are a BUY (50%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4
$2.59 (183.69%)
6 months 27 days ago
1/2 (50%)
$2.6 (185.71%)
49
What is CYTH (Cyclo Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CYTH (Cyclo Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CYTH (Cyclo Therapeutics)?
Which analyst is the currently most bullish on CYTH (Cyclo Therapeutics)?